Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulcrum Therapeutics (FULC) Receivables - Net: 2020-2021

Historic Receivables - Net for Fulcrum Therapeutics (FULC) over the last 2 years, with Dec 2021 value amounting to $2.5 million.

  • Fulcrum Therapeutics' Receivables - Net was N/A to $13,000 in Q3 2022 from the same period last year, while for Sep 2022 it was $13,000, marking a year-over-year change of. This contributed to the annual value of $2.5 million for FY2021, which is 25.00% up from last year.
  • Per Fulcrum Therapeutics' latest filing, its Receivables - Net stood at $2.5 million for FY2021, which was up 25.00% from $2.0 million recorded in FY2020.
  • In the past 5 years, Fulcrum Therapeutics' Receivables - Net registered a high of $2.5 million during FY2021, and its lowest value of $2.0 million during FY2020.
  • In the last 2 years, Fulcrum Therapeutics' Receivables - Net had a median value of $2.2 million in 2020 and averaged $2.2 million.
  • Data for Fulcrum Therapeutics' Receivables - Net shows a peak YoY grew of 25.00% (in 2021) over the last 5 years.
  • Fulcrum Therapeutics' Receivables - Net (Yearly) stood at $2.0 million in 2020, then climbed by 25.00% to $2.5 million in 2021.